
Voronoi Inc.
South Korea · Research
Research
Pharmaceuticals
Biotechnology
Healthcare
VORONOI, a leading biotech in South Korea EGFR-Exon20Ins Lisenced out to ORIC Parmaceuticals in 2020 RET-Fusion Lisenced out to Inno.N in 2021 Anticipated upcoming IPO on KOSDAQ for 4Q, 2021
2015
Founded
Research
Industry
South Korea
Location
6,456,562
Ranking
200 employees
Size

Get full access to view complete information

© Pubrio 2026